Rob Melief

Rob Melief currently serves as the Medical Director for Seagen Benelux at Pfizer, where he plays a pivotal role in advancing the company's oncology portfolio within the Benelux region. In this capacity, Rob leverages over two decades of experience in the pharmaceutical industry to lead medical operations, ensuring the seamless integration of scientific excellence with strategic business objectives. His expertise encompasses the development and execution of medical strategies that support innovative oncology therapies, with a strong focus on fostering transparent collaboration with healthcare professionals, key opinion leaders, and patient advocacy groups.

Rob’s current role involves overseeing medical affairs activities, including medical science liaison initiatives, pharmacovigilance, and the dissemination of clinical data to support product positioning and market access. He is instrumental in driving cross-functional projects aimed at enhancing patient care and optimizing the medical and scientific engagement strategies within the region. As a member of the Benelux Management Team, Rob contributes to strategic decision-making, particularly in re-organizing and streamlining medical operations to adapt to evolving industry landscapes and regulatory environments.

His key projects include the implementation of educational programs for healthcare providers, the development of real-world evidence generation initiatives, and the strengthening of relationships with key stakeholders to ensure the safe and effective use of oncology medicines. Rob’s leadership is characterized by a patient-centric approach, emphasizing quality improvement, interdisciplinary collaboration, and strategic communications. His extensive background in oncology, combined with his skills in relationship building, executive management, and pharmacovigilance, positions him as a trusted partner in advancing Pfizer’s mission to improve patient outcomes across the Benelux region.